Clinical trial NCT00761124: Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men
Official title: Informed Decision-Making Regarding PSA Screening
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: Prostate Cancer
Keywords: PSA screening
Prostate cancer and Latino men
Lead sponsor: Jonsson Comprehensive Cancer Center
Sponsor class: OTHER
Collaborators: name: National Cancer Institute (NCI)
First posted: 2008-09-29
Enrollment: 1006
Sex: MALE
Minimum age (years): 50
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: The purpose of this intervention trial is aiming to increase inform decision- making in Latino men regarding prostate cancer screening.

The investigators propose to find out how much Latino men know about the benefits and risks of prostate cancer screening and what factors influence how they decide whether or not to have screening. The investigators are also interested in learning how providing education information, both verbally and in print, about the risks and benefits of prostate cancer screening affects men's interest and knowledge.

The intervention is an interactive multi-media presentation made up of a small group of 8-10 Latino men gathered to discuss about prostate cancer, screening methods, treatment, and the controversy within the medical community regarding PSA screening. A facilitator guides the 1-hour discussion and encourages participant interaction. The effect of this intervention was tested on 1000 Latino men within Los Angeles county.

Participants were recruited from 38 community venues (churches, community center, etc.). All participants were interviewed before being randomized to receive written (control group) or oral (intervention) prostate cancer education material. All of the participants will be followed up at 6-months via a telephone interview.

The investigators hypothesize that the intervention group will have an increase knowledge of prostate cancer, will have increase communication with family, friends, and medical provider, and will have an increase rate of PSA screening compared to the control group.


Eligibility criteria: Inclusion Criteria:

* Latino men
* 50 to 70 years old
* Not ever having prostate biopsy
* Not ever having prostate cancer
* Not having had a PSA test within the past 12 months
* Not having BPH (prostate inflammation)
* Not currently experiencing prostate problems such as pain or burning sensation during urination, blood in urine, and/or desire to urinate frequently

Exclusion Criteria:

* Not Latino
* Younger than 50 or older than 70 years old
* Currently experiencing prostate problems such as pain or burning sensations while urinating, blood in urine, and/or desire to urinate frequently
* Living outside of Los Angeles county
* Having had a prostate biopsy
* Having had prostate cancer previously
* Having had a prostatectomy

Primary outcomes:
measure: Inform Decision-Making
timeFrame: 6 months post-baseline interview
Secondary outcomes:
measure: Prostate cancer knowledge, Receipt of PSA, and Communication with family, friends, and medical providers
timeFrame: 6 months post-baseline interview
Other outcomes:
Locations:
city: Los Angeles
country: United States
facility: UCLA, Division of Cancer Prevention and Control Research
state: California
Study officials:
affiliation: University of California, Los Angeles
name: Roshan Bastani, PhD
role: PRINCIPAL_INVESTIGATOR
References: